Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of microbiota in the development of colorectal cancer
Zhujiang Dai, Jingqiu Zhang, Qi Wu, et al.
International Journal of Cancer (2018) Vol. 145, Iss. 8, pp. 2032-2041
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Microbiota in health and diseases
Kejun Hou, Zhuo‐Xun Wu, Xuan-Yu Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1540
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Mingyang Song, Andrew T. Chan, Jun Sun
Gastroenterology (2019) Vol. 158, Iss. 2, pp. 322-340
Open Access | Times Cited: 591
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Ester Saus, Susana Iraola‐Guzmán, Jesse R. Willis, et al.
Molecular Aspects of Medicine (2019) Vol. 69, pp. 93-106
Open Access | Times Cited: 297
Exploring the Role of Gut Microbiome in Colon Cancer
Indranil Chattopadhyay, Ruby Dhar, Karthikeyan Pethusamy, et al.
Applied Biochemistry and Biotechnology (2021) Vol. 193, Iss. 6, pp. 1780-1799
Closed Access | Times Cited: 105
Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation
Olga Brusnic, Danusia Onișor, Adrian Boicean, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6578-6578
Open Access | Times Cited: 26
Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics
Karolina Kaźmierczak-Siedlecka, Agnieszka Daca, Mateusz Fic, et al.
Gut Microbes (2020) Vol. 11, Iss. 6, pp. 1518-1530
Open Access | Times Cited: 135
Fecal microbiota transplantation beyond Clostridioides difficile infections
Koen Wortelboer, Max Nieuwdorp, Hilde Herrema
EBioMedicine (2019) Vol. 44, pp. 716-729
Open Access | Times Cited: 132
Obesity, Inflammation, and Prostate Cancer
Kazutoshi Fujita, Takuji Hayashi, Makoto Matsushita, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 2, pp. 201-201
Open Access | Times Cited: 120
Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004‐2015
John Virostko, Anna Capasso, Thomas E. Yankeelov, et al.
Cancer (2019) Vol. 125, Iss. 21, pp. 3828-3835
Open Access | Times Cited: 92
The roles of microbial products in the development of colorectal cancer: a review
Yongkun Fang, Cheng Yan, Qi Zhao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 720-735
Open Access | Times Cited: 87
Gut microbiota-derived metabolites in CRC progression and causation
Nishu Dalal, Rekha Jalandra, Nitin Bayal, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 11, pp. 3141-3155
Closed Access | Times Cited: 73
Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis
Karolina Kaźmierczak-Siedlecka, Aleš Dvořák, Marcin Folwarski, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1326-1326
Open Access | Times Cited: 71
Mycobiome and Cancer: What Is the Evidence?
Natalia G. Vallianou, Dimitris Kounatidis, Gerasimos Socrates Christodoulatos, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3149-3149
Open Access | Times Cited: 64
Role of probiotics and prebiotics in mitigation of different diseases
Sabeena Manzoor, Shoib Mohmad Wani, Sajad Ahmad Mir, et al.
Nutrition (2022) Vol. 96, pp. 111602-111602
Closed Access | Times Cited: 51
The role of gut microbiome in cancer genesis and cancer prevention
Noor Akbar, Naveed Ahmed Khan, Jibran Sualeh Muhammad, et al.
Health Sciences Review (2022) Vol. 2, pp. 100010-100010
Open Access | Times Cited: 44
Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
Suwen Ou, Hufei Wang, Yangbao Tao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 42
Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms
Yufei Liu, Zhangming Pei, Tong Pan, et al.
Microbiological Research (2023) Vol. 272, pp. 127392-127392
Open Access | Times Cited: 29
The involvement of Th1 cell differentiation in the anti-tumor effect of purified polysaccharide from Sanghuangporus vaninii in colorectal cancer via multi-omics analysis
Yidi Qu, Hongxin Yang, Siyu Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 237, pp. 123927-123927
Closed Access | Times Cited: 23
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 221-221
Open Access | Times Cited: 15
Intestinal microbiota: a new force in cancer immunotherapy
Zhujiang Dai, Jingqiu Zhang, Qi Wu, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers
Karolina Kaźmierczak-Siedlecka, Giandomenico Roviello, Martina Catalano, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2674-2674
Open Access | Times Cited: 51
The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Nikolaos Spyrou, Natalia G. Vallianou, Jona Kadillari, et al.
Seminars in Cancer Biology (2021) Vol. 73, pp. 356-376
Closed Access | Times Cited: 46
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Yun Chen, Boyuan Liu, Wei Yuan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105966-105966
Closed Access | Times Cited: 45
Early-onset cancers: Biological bases and clinical implications
Gianluca Mauri, Giorgio Patelli, Andrea Sartore‐Bianchi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101737-101737
Open Access | Times Cited: 7
Disruption of the intestinal clock drives dysbiosis and impaired barrier function in colorectal cancer
Rachel C. Fellows, Sung Kook Chun, Natalie Larson, et al.
Science Advances (2024) Vol. 10, Iss. 39
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top